EdgarLookup

MapLight Therapeutics, Inc. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
Novo Holdings A/S C 2,733,681 2,733,681 Oct 28, 2025
Catalyst4, Inc. C 14,256,288 14,256,288 Oct 28, 2025
Malenka Robert C. Award / Grant 34,390 399,671 Oct 28, 2025
Kroeger Christopher A. Chief Executive Officer Award / Grant 225,693 225,693 Oct 28, 2025
Garnett Timothy John Award / Grant 6,294 6,294 Oct 27, 2025
Walker Maria C Award / Grant 6,294 6,294 Oct 27, 2025
Hanson Kristopher General Counsel Award / Grant 27,098 27,098 Oct 27, 2025
GILLIS JONATHAN CAAO and PAO Award / Grant 30,565 30,565 Oct 27, 2025
Kreitzer Anatol Chief Discovery Officer Award / Grant 35,953 35,953 Oct 27, 2025
Lillie James Woodruff Chief Scientific Officer Award / Grant 32,539 32,539 Oct 27, 2025
Setia Vishwas Chief Financial Officer Award / Grant 43,367 43,367 Oct 27, 2025
Foff Erin Pennock Chief Medical Officer Award / Grant 48,275 48,275 Oct 27, 2025